GlassScriptPhysician profile
Jimmy H Jee
NPI 1396807905
$1,107.23
in general payments reported to CMS, 2019-2025
14 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $58.03 · 2021: $200 · 2022: $196 · 2023: $78.31 · 2024: $238 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $233.53 | 2019-2025 | |
| Oyster Point Pharma, INC. | $132.65 | 2022-2024 | Tyrvaya |
| Bausch & Lomb Americas INC. | $119.29 | 2022-2024 | Miebo, Xiidra, Vyzulta |
| Harrow Eye, LLC | $118.67 | 2024-2025 | Vevye |
| Eyevance Pharmaceuticals LLC | $118.07 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $107.74 | 2021-2022 | |
| Glaukos Corporation | $101.95 | 2019 | |
| Allergan, INC. | $44.78 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $35.89 | 2024 | Xdemvy |
| Abbvie INC. | $29.83 | 2022 | |
| Thea Pharma INC. | $18.73 | 2024 | Iyuzeh |
| Alcon Vision LLC | $17.02 | 2025 | Tryptyr |
| Currax Pharmaceuticals LLC | $16.49 | 2021 | |
| Shire North American Group INC | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jimmy Jee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.